IIC
IDXX icon

Integrated Investment Consultants’s Idexx Laboratories IDXX Stock Holding History

Integrated Investment Consultants’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Buy
443
+8
+2% +$4.49K 0.05% 244
2026
Q1 		$244K Buy
435
+6
+1% +$3.85K 0.05% 228
2025
Q4 		$290K Sell
429
-9
-2% -$6.13K 0.06% 206
2025
Q3 		$280K Hold
438
– – 0.05% 256
2025
Q2 		$235K Buy
+438
New +$209K 0.05% 287
2024
Q4 		– Sell
-650
Closed -$328K – 332
2024
Q3 		$328K Buy
650
+212
+48% +$103K 0.07% 215
2024
Q2 		$236K Hold
438
– – 0.07% 223
2024
Q1 		$236K Sell
438
-3
-0.7% -$1.64K 0.07% 223
2023
Q4 		$245K Buy
+441
New +$207K 0.08% 206
2023
Q3 		– Sell
-465
Closed -$234K – 252
2023
Q2 		$234K Buy
465
+8
+2% +$3.83K 0.07% 233
2023
Q1 		$229K Buy
+457
New +$219K 0.07% 241
2022
Q2 		– Sell
-453
Closed -$248K – 278
2022
Q1 		$248K Sell
453
-7
-2% -$3.68K 0.07% 252
2021
Q4 		$303K Buy
460
+7
+2% +$4.39K 0.08% 230
2021
Q3 		$282K Hold
453
– – 0.08% 218
2021
Q2 		$286K Hold
453
– – 0.08% 216
2021
Q1 		$222K Hold
453
– – 0.08% 236
2020
Q4 		$226K Buy
+453
New +$203K 0.09% 214

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Integrated Investment Consultants's IDXX Position: Q2 2026 in Review

Integrated Investment Consultants increased its Idexx Laboratories (IDXX) stake by 1.8% in Q2 2026, buying an estimated $4.49K and bringing the position to 443 shares worth $233K. The position accounts for 0.05% of the portfolio, ranked #244.

Integrated Investment Consultants first reported a position in IDXX in Q4 2020 and has held it in 17 quarters since. The position peaked at $328K in Q3 2024. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Integrated Investment Consultants held 443 shares of Idexx Laboratories worth $233K as of Q2 2026.
  • Integrated Investment Consultants bought 8 Idexx Laboratories shares in Q2 2026, an estimated $4.49K.
  • Idexx Laboratories made up 0.05% of Integrated Investment Consultants's portfolio in Q2 2026, its #244 holding.
  • Integrated Investment Consultants first reported a position in Idexx Laboratories in Q4 2020 and has held it in 17 quarters since.
  • Integrated Investment Consultants's Idexx Laboratories position peaked at $328K in Q3 2024.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Integrated Investment Consultants's 13F filing for Q2 2026, filed 17 Aug 2026.